Medical Disorders
Resources
Basic InformationLookupsLatest News
When Is It Time for a Knee Replacement?AHA News: Death Rates From Tears In This Major Heart Artery Are Rising, Especially Among Women, Black AdultsOmicron COVID Causing Severe Croup in Young Children'Zapping' Air Passages May Bring Relief for Severe AsthmaModerna Asks FDA to Approve Second Booster for All AdultsNew Tick-Borne Virus Is Spreading Across U.S.Memory Issues Plague Long COVID PatientsCOVID Vaccine Won't Cause Rare Neuro Events, But COVID Infection CouldIt Can Take Weeks for Some Patients With Severe COVID to Recover ConsciousnessOmicron Wave Had 5 Times as Many Small Kids Hospitalized Compared to DeltaPalliative Care Crucial After Severe Stroke, But Many Patients Miss OutMammograms Can Also Highlight Heart Risks: StudyPfizer Asks FDA to Approve Second Booster for SeniorsEven a Little Light in Your Bedroom Could Harm HealthRise in U.K. COVID Cases Closely Watched by U.S. Health OfficialsLong COVID May Bring Long-Term Lung DamageNew Malaria Treatment Gets First Approval for Use in ChildrenAbout 1 in 6 U.S. Couples Disagrees on COVID VaccinationCOVID Meds Appear to Work Against BA.2 Omicron VariantCould Depression Make Dry Eye Worse?When Will Americans With Diabetes Get Relief From High Insulin Prices?COVID's Global Death Toll May Be 3 Times Official NumbersDrug Could Be Non-Antibiotic Alternative to Treat UTIsFlu Vaccine No Match for Circulating Variants This SeasonLymphedema in Legs Strikes 1 in 3 Female Cancer SurvivorsScience Brings Shortcut to Spotting 50 Rare Genetic DiseasesU.S. Airplane, Train and Transit Mask Mandates Extended to April 18Man Who Received First Pig Heart Transplant Has DiedPfizer Begins Trial of COVID Drug Paxlovid in Kids 6 to 17Could a Stool Test Help Spot Pancreatic Cancer?Upcoming Surgery Worry You? Poll Says You're Not AloneHalf of Americans Live With Legacy of Childhood Lead PoisoningIn Reversal, WHO Now Supports COVID BoostersLooking to Neanderthals to Explain Today's Lower Back PainWhat's More Accurate, Blood Pressure Readings at Home or Doctor's Office?Begin Now to Protect Your Heart as Clocks 'Spring Forward'Brain Changes May Fuel 'Long COVID' Anxiety, ConfusionHow COVID-19 Can Change the BrainHeart Defects Could Raise Odds for Severe COVID-196 Healthy Steps to Preventing Colon CancerAHA News: These Three Risk Factors May Have the Biggest Impact on Dementia CasesU.S. Surgeon General Investigates COVID-19 MisinformationCould Your Blood Type Make COVID Worse?Implanted 'Drug Factory' Wipes Out Cancers in Mice -- Could It Help People?Immunization Against Common Infection of Babies Could Be NearTelemedicine Helped Many MS Patients During PandemicMore Years Playing Hockey, Higher Odds for CTE Linked to Head InjuryWhite House Unveils New COVID Response StrategyVariants of COVID Virus May 'Hide Out' in Body: StudyInfected People Gain Long-Lasting Immunity Against Coronavirus: Study
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Pfizer Asks FDA to Approve Second Booster for Seniors


HealthDay News
Updated: Mar 16th 2022

new article illustration

WEDNESDAY, March 16, 2022 (HealthDay News) -- Pfizer Inc. said Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster shot for Americans 65 and older.

In a statement announcing its request, Pfizer relied on data from two studies out of Israel that have been published without peer review on pre-print servers.

The first study, conducted in concert with Israel’s Ministry of Health, reviewed the health records of 1.1 million people and concluded that they were less likely to become infected or develop severe illness after a fourth dose of Pfizer’s vaccine. However, Israel only recently began its second booster program, so it was unclear how long the extra protection might last. Israel began offering fourth doses to health care workers in late December, then quickly broadened eligibility to those 60 and older and other vulnerable groups.

The second study, of Israeli health care workers, showed that while fourth shots of either Pfizer’s or Moderna’s vaccine boosted antibody levels, it was not very effective at preventing infections. Researchers said those findings underscored the urgency of developing vaccines that target whatever variant is circulating.

Still, "both data sets showed evidence that an additional mRNA booster increases immunogenicity and lowers rates of confirmed infections and severe illness," the company said in its statement.

Pfizer CEO Dr. Albert Bourla has said more than once in the past week that the company believes a fourth shot will be needed to counter the waning power of the third shot.

A meeting of an FDA expert advisory committee to discuss the issue of second booster shots is expected to be held next month, The New York Times reported.

While a fourth shot for all older Americans without weakened immune systems may be a good idea now, giving extra booster shots to the general population should probably be put on hold until the fall, some senior Biden administration officials suggest.

“Barring any surprises from new variants, maybe the best thing is to think about our booster strategy in conjunction with the influenza vaccine next fall, and get as many people as possible boosted then," Dr. Peter Marks, the FDA's top vaccine regulator, told the Times last month.

Any recommendation on a second booster shot would likely target people most at risk, possibly based on underlying conditions as well as age, Dr. Anthony Fauci, chief medical adviser to the White House, has said.

In addition, the administration is running short on funds for COVID vaccines, a senior White House official told reporters on condition of anonymity Tuesday, the Times reported. The official said there is enough money to cover fourth shots for people with weakened immune systems, but additional funding from Congress would be needed to pay for second boosters for all Americans.

A U.S. Centers for Disease Control and Prevention study released last month showed that protection began to weaken after a booster shot of either the Pfizer or Moderna vaccine, but it did not analyze cases by age, immune deficiencies or underlying health conditions.

More information

Visit the U.S. Food and Drug Administration for more on COVID boosters.


SOURCE: The New York Times




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net